Moderna (MRNA) EBITDA US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
EBITDA, bln rub | ? | -763.1 | 13 296 | 9 923 | 9 768 | -3 211 | -4 015 | ||
Changes by years, y/y, % | +40% | -1 842% | -25% | -2% | -133% | +50.7% |
Moderna. EBITDA US GAAP, bln rub
Moderna. EBITDA US GAAP, changes, %
Moderna. EBITDA US GAAP, sum by quarters, bln rub
Moderna (MRNA) EBITDA US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
EBITDA, bln rub | ? | -2 012 | -1 763 | 300.0 | -1 230 | -1 322 | -4 015 | |
Changes by years, y/y, % | -250% | -231% | -81% | +327% | -26% | |||
Changes by quarters, q/q, % | +13% | -12% | -117% | -510% | +7% |